Danaher Co. Plans Quarterly Dividend of $0.27 (NYSE:DHR)

Danaher Co. (NYSE:DHR) announced a quarterly dividend on Tuesday, December 10th,RTT News reports. Investors of record on Friday, December 27th will be given a dividend of 0.27 per share by the conglomerate on Friday, January 31st. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%.

Danaher has increased its dividend payment by an average of 13.4% per year over the last three years. Danaher has a payout ratio of 12.9% meaning its dividend is sufficiently covered by earnings. Analysts expect Danaher to earn $8.38 per share next year, which means the company should continue to be able to cover its $1.08 annual dividend with an expected future payout ratio of 12.9%.

Danaher Trading Up 1.3 %

Shares of Danaher stock traded up $2.99 during trading hours on Wednesday, reaching $237.33. 211,544 shares of the company’s stock were exchanged, compared to its average volume of 2,767,756. Danaher has a 52-week low of $218.48 and a 52-week high of $281.70. The firm has a market capitalization of $171.42 billion, a price-to-earnings ratio of 44.74, a price-to-earnings-growth ratio of 4.23 and a beta of 0.83. The company has a fifty day moving average of $249.91 and a 200-day moving average of $258.14. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period last year, the company posted $2.02 EPS. Sell-side analysts forecast that Danaher will post 7.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on DHR shares. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Thursday, December 5th. Royal Bank of Canada lowered their target price on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a research note on Thursday, October 31st. Barclays lowered their target price on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 23rd. Finally, TD Cowen lifted their price target on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.